Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
SR

Svante Ross — 29 Patents

Astrazeneca Ab: 15 patents #39 of 1,971Top 2%
ACAstra Co.: 11 patents #14 of 446Top 4%
AAAstra Lakemedel Aktiebolag: 3 patents #8 of 84Top 10%
Gately Drive, SE: #1 of 315 inventorsTop 1%
Overall (All Time): #127,851 of 4,157,543Top 4%
29 Patents All Time
Svante Ross has been granted 29 US patents while listed as an inventor at Astrazeneca Ab. The first was granted in 1980 and the most recent in October 2008. Svante Ross ranks #127,851 of 4,157,543 US inventors in our database (top 3.1%). Patent records list Svante Ross in Gately Drive, SE.

Issued Patents All Time

Showing 1–25 of 29 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
7439356 Substituted indan derivatives Stefan Berg, Lennart Florvall, Seth-Olov Thorberg 2008-10-21 $12,560,000
7384943 Substituted chroman derivatives Stefan Berg, Martin Nylof, Seth-Olov Thorberg 2008-06-10 $5,253,000
7056921 Substituted chroman derivatives Stefan Berg, Martin Nylof, Seth-Olov Thorberg 2006-06-06 $12,341,000
6670359 Substituted chroman derivatives Stefan Berg, Martin Nylof, Seth-Olov Thorberg 2003-12-30 $18,737,000
6548498 Substituted indan derivatives Stefan Berg, Lennart Florvall, Seth-Olov Thorberg 2003-04-15 $7,624,000
6534652 Intermediates for the preparation of substituted 1,2,3,4-tetrahydronaphthalene derivatives Stefan Berg, Seth-Olov Thorberg 2003-03-18 $30,300,000
6479497 Substituted chroman derivatives Stefan Berg, Martin Nylof, Seth-Olov Thorberg 2002-11-12 $6,401,000
6472423 Pharmaceutical composition Seth-Olov Thorberg 2002-10-29 $14,987,000
6410530 Substituted 1,2,3,4-tetrahydronaphthalene derivatives Stefan Berg, Lennart Florvall, Seth-Olov Thorberg 2002-06-25 $8,476,000
6410532 Substituted 1,2,3,4-tetrahydronaphthalene derivatives Stefan Berg, Mats Linderberg, Seth-Olov Thorberg, Bengt Ulff 2002-06-25 $8,476,000
6387899 Substituted chroman derivatives Stefan Berg, Mats Linderberg, Seth-Olov Thorberg, Bengt Ulff 2002-05-14 $13,320,000
6384225 Intermediates in the preparation of substituted chroman derivatives Stefan Berg, Mats Linderberg, Seth-Olov Thorberg, Bengt Ulff 2002-05-07 $6,517,000
6313118 Substituted 1,2,3,4-tetrahydronaphthalene derivatives Stefan Berg, Mats Linderberg, Seth-Olov Thorberg, Bengt Ulff 2001-11-06
6159970 Combination of a monoamine oxidase inhibitor and a h5-HT.sub.1B antagonist or partial agonist Stefan Berg, Seth-Olov Thorberg 2000-12-12 $8,539,000
6159971 Combination of a 5-HT reuptake inhibitor and a H5-HT1B anatagonist or partial agonist Stefan Berg, Seth-Olov Thorberg 2000-12-12 $8,539,000
6159972 Combination of a selective 5-HT.sub.1A antagonist and a selective ub . h5-HT.s1B antagonist or partial agonist Stefan Berg, Seth-Olov Thorberg 2000-12-12 $8,539,000
6124283 Substituted 1,2,3,4-tetrahydronaphthalene derivatives Stefan Berg, Lennart Florvall, Seth-Olov Thorberg 2000-09-26
5656658 Method for the treatment of anxiety Eva Maria Hammarberg, Lars George Johansson, Lars-Gunnar Larsson, Rolf Noreen, Lucy Anna Renyi +3 more 1997-08-12
5656657 Chroman derivatives Eva Maria Hammarberg, Lars George Johansson, Lars-Gunnar Larsson, Rolf Noreen, Lucy Anna Renyi +3 more 1997-08-12
5646309 Intermediates in the synthesis of chroman derivatives Eva Maria Hammarberg, Lars George Johansson, Lars-Gunnar Larsson, Rolf Noreen, Lucy Anna Renyi +3 more 1997-07-08
5641807 Method for the treatment of depression Eva Maria Hammarberg, Lars George Johansson, Lars-Gunnar Larsson, Rolf Noreen, Lucy Anna Renyi +3 more 1997-06-24
5639784 Method for the treatment of migraine Eva Maria Hammarberg, Lars George Johansson, Lars-Gunnar Larsson, Rolf Noreen, Lucy Anna Renyi +3 more 1997-06-17
5639772 Chroman derivatives Eva Maria Hammarberg, Lars George Johansson, Lars-Gunnar Larsson, Rolf Noreen, Lucy Anna Renyi +3 more 1997-06-17
5616610 (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzo pyrans John Evenden, Eva Maria Hammarberg, Hans S. Hansson, Sven Hellberg, Lars George Johansson +3 more 1997-04-01
5500425 Chroman derivatives and a method of treating 5-HT mediated disorders Lars-Gunnar Larsson, Lucy A. Renyl, Daniel Sohn, Seth-Olov Thorberg 1996-03-19